
Sign up to save your podcasts
Or


When we think about medicine’s war on cancer, treatments such as surgery, radiation and chemotherapy spring to mind first. Now there is another potential weapon for defeating tumors: statistics and mathematical models that can optimize the selection, combination or timing of treatment. Building and feeding these models requires accounting for the complexity of the body, and recognizing that cancer cells are constantly evolving.
In this episode, host Steven Strogatz hears from Franziska Michor, a computational biologist, about how our understanding of evolutionary dynamics is being used to devise new anticancer therapies.
By Steven Strogatz, Janna Levin and Quanta Magazine4.9
482482 ratings
When we think about medicine’s war on cancer, treatments such as surgery, radiation and chemotherapy spring to mind first. Now there is another potential weapon for defeating tumors: statistics and mathematical models that can optimize the selection, combination or timing of treatment. Building and feeding these models requires accounting for the complexity of the body, and recognizing that cancer cells are constantly evolving.
In this episode, host Steven Strogatz hears from Franziska Michor, a computational biologist, about how our understanding of evolutionary dynamics is being used to devise new anticancer therapies.

324 Listeners

837 Listeners

563 Listeners

535 Listeners

247 Listeners

1,070 Listeners

82 Listeners

4,196 Listeners

2,362 Listeners

448 Listeners

507 Listeners

252 Listeners

329 Listeners

23 Listeners

390 Listeners

505 Listeners